Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NasoClenz is a healthcare company specializing in advanced nasal hygiene and infection prevention solutions. The company's flagship product is a patented nasal cleansing system that combines an anatomically designed swab with a proprietary antiseptic gel to effectively decolonize the nasal vestibule. Designed by an otolaryngologist, the system is used in clinical settings to reduce the risk of surgical site infections by targeting pathogens like MRSA before procedures. Additionally, NasoClenz offers consumer products for daily respiratory wellness and post-operative recovery, providing a comfortable alternative to traditional nasal irrigation. The company focuses on improving patient outcomes through simple, non-invasive microbial reduction in the nose.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NasoClenz.